676 Results

People

  1. Robson
    Robson
  2. Offit
    Offit
  3. Stadler
    Stadler
  4. Joseph
    Joseph
  5. Mandelker
    Mandelker
  6. Berger
    Berger
  7. Solit
    Solit
  8. Hudis
    Hudis
  9. Kauff
    Kauff
  10. Kemel
    Kemel

Groups

  1. Breast Medicine Service (676)
  2. Department of Medicine (676)
  3. Population Sciences Research Program (676)
  4. Solid Tumor Oncology Division (676)
  5. Survivorship Research (676)
  6. GSK Faculty (376)
  7. Clinical Genetics Service (297)
  8. Surgery (188)
  9. Department of Pathology and Laboratory Medicine (187)
  10. Epidemiology and Biostatistics (185)
  1. "Mark Robson"
Formats
  1. Journal Article (382)
  2. Meeting Abstract (259)
  3. Review (10)
  4. Book Section (7)
  5. Editorial (6)
  6. Guidelines (6)
  7. Miscellaneous (4)
  8. Correspondence (1)
  9. Research Letter (1)
Groups
  1. Breast Medicine Service (676)
  2. Department of Medicine (676)
  3. Population Sciences Research Program (676)
  4. Solid Tumor Oncology Division (676)
  5. Survivorship Research (676)
  6. GSK Faculty (376)

More Groups

People
  1. Mark Robson (676)
  2. Kenneth Offit (280)
  3. Zsofia Stadler (116)
  4. Larry Norton (89)
  5. Vijai Joseph (79)
  6. Diana Mandelker (74)

More People

Years
  1. 2025 (2)
  2. 2024 (32)
  3. 2023 (41)
  4. 2022 (34)
  5. 2021 (46)
  6. 2020 (65)

More Years

Publications
  1. Journal of Clinical Oncology (163)
  2. Cancer Research (50)
  3. Breast Cancer Research and Treatment (33)
  4. JNCI: Journal of the National Cancer Institute (20)
  5. Annals of Oncology (18)
  6. Clinical Cancer Research (17)

More Publications

Publishers
  1. American Society of Clinical Oncology (185)
  2. American Association for Cancer Research (82)
  3. Springer (66)
  4. Nature Publishing Group (60)
  5. Elsevier Inc. (50)
  6. Oxford University Press (42)

More Publishers

Results (676)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: Genome-wide association studies of the estrone pathway
    Journal Article

    Dudenkov, T. M.; Ingle, J. N.; Buzdar, A. U.; Robson, M. E.; Kubo, M.; Ibrahim-zada, I.; Batzler, A.; Jenkins, G. D.; Pietrzak, T. L.; Carlson, E. E.; more...
    Breast Cancer Research and Treatment (2017)

    Fulltext@MSK | Save
  • Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
    Journal Article

    Zehir, A.; Benayed, R.; Shah, R. H.; Syed, A.; Middha, S.; Kim, H. R.; Srinivasan, P.; Gao, J.; Chakravarty, D.; Devlin, S. M.; more...
    Nature Medicine (2017)

    Fulltext@MSK | Save
  • Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing
    Journal Article

    Cheng, D. T.; Prasad, M.; Chekaluk, Y.; Benayed, R.; Sadowska, J.; Zehir, A.; Syed, A.; Wang, Y. E.; Somar, J.; Li, Y.; more...
    BMC Medical Genomics (2017)

    Fulltext@MSK | Save
  • Illustrating cancer risk: Development of breast cancer risk communication materials for a novel BRCA1/2 genetic modifier test
    Meeting Abstract

    Genoff, M. C.; Westerman, J. S.; Shuk, E.; Hay, J. L.; Offit, K.; Robson, M. E.; Hamilton, J. G.
    Annals of Behavioral Medicine (2017)

    Fulltext@MSK | Save
  • Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
    Journal Article

    Phelan, C. M.; Kuchenbaecker, K. B.; Tyrer, J. P.; Kar, S. P.; Lawrenson, K.; Winham, S. J.; Dennis, J.; Pirie, A.; Riggan, M. J.; Chornokur, G.; more...
    Nature Genetics (2017)

    Fulltext@MSK | Save
  • Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers
    Journal Article

    Krammer, J.; Pinker-Domenig, K.; Robson, M. E.; Gönen, M.; Bernard-Davila, B.; Morris, E. A.; Mangino, D. A.; Jochelson, M. S.
    Breast Cancer Research and Treatment (2017)

    Fulltext@MSK | Save
  • Efficacy and tolerability of veliparib (V; ABT-888) in combination with carboplatin (C) and paclitaxel (P) vs placebo (Plc)+C/P in patients (pts) with BRCA1 or BRCA2 mutations and metastatic breast cancer: A randomized, phase 2 study
    Meeting Abstract

    Han, H. S.; Dieras, V.; Robson, M. E.; Palacova, M.; Marcom, P. K.; Jager, A.; Bondarenko, I.; Citrin, D.; Campone, M.; Telli, M. L.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Evaluation of veliparib (V) and temozolomide (TMZ) in a phase 2 randomized study of the efficacy and tolerability of V plus TMZ or carboplatin (C) and paclitaxel (P) vs placebo (Plc) plus C/P in patients (pts) with BRCA1 or BRCA2 mutations and metastatic breast cancer
    Meeting Abstract

    Dieras, V.; Han, H. S.; Robson, M. E.; Palacova, M.; Marcom, P. K.; Jager, A.; Bondarenko, I.; Citrin, D.; Campone, M.; Telli, M. L.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • The landscape of somatic genetic alterations in BRCA1 and BRCA2 breast cancers
    Meeting Abstract

    Geyer, F. C.; Burke, K. A.; Macedo, G. S.; Piscuoglio, S.; Ng, C. K.; Martelotto, L. G.; Papanastatiou, A. D.; De Filippo, M. R.; Schultheis, A. M.; Brogi, E.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • CSMD1 SNPs selectively affect anastrozole response in postmenopausal breast cancer patients
    Meeting Abstract

    Cairns, J.; Ingle, J.; Dudenkov, T.; Kalari, K.; Buzdar, A.; Kubo, M.; Robson, M.; Ellis, M.; Goss, P.; Shepherd, L.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save